{"id":"W4401560936","doi":"10.1056/nejme2406495","title":"Osimertinib in Stage III <i>EGFR</i> -Mutated NSCLC — Game, Set, Match","year":2024,"lang":"en","type":"editorial","venue":"New England Journal of Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"KRAS; Osimertinib; ROS1; Epidermal growth factor receptor; Tyrosine kinase; Lung cancer; Cancer research; Medicine; Oncology; Internal medicine; Personalized medicine; Erlotinib; Cancer; Biology; Bioinformatics; Receptor; Adenocarcinoma; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005285647,0.002406104,0.00214997,0.001440564,0.001443404,0.003251369,0.00259309,0.009229341,0.005761273],"category_scores_gemma":[0.01039157,0.0006572129,0.001772558,0.0007857673,0.001245837,0.003576307,0.0009186377,0.01995003,0.004860934],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002400899,"about_ca_system_score_gemma":0.001880635,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001836843,"about_ca_topic_score_gemma":0.004780267,"domain_scores_codex":[0.9981576,0.0004187741,0.0002303559,0.0002320838,0.0008319973,0.000129295],"domain_scores_gemma":[0.995528,0.002222617,0.0002307456,0.0001092945,0.001162701,0.0007466534],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001407669,0.00002522653,0.00002263926,0.0002217962,0.00002438784,0.0001012565,0.000009264671,0.00004436524,0.00008641327,0.0005872119,0.9820901,0.01664655],"study_design_scores_gemma":[0.000296427,0.0001646694,0.0004334535,0.0006486072,0.0001046231,0.0003346734,0.00003163704,0.0003272966,0.0002137871,0.001881206,0.9955384,0.00002509093],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.000158415,0.02587215,0.0002508198,0.06408137,0.905006,0.00005297896,0.00012241,0.0001083437,0.004347509],"genre_scores_gemma":[0.001061813,0.01862391,0.0002162897,0.05784738,0.9089528,0.00004868094,0.00007358396,0.00005241719,0.01312315],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.009229341,"threshold_uncertainty_score":0.02795351,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0134606768944262,"score_gpt":0.3453272976438109,"score_spread":0.3318666207493847,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}